Form D · Pharmaceuticals
ORAMED PHARMACEUTICALS INC.
Jerusalem, L3 · CIK 0001176309
Offering snapshot reported Nov 14, 2014 · SEC filing
- Reported sold
- Yet to sell Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $5M Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 14, 2014 | Initial | Yet to sell | No comparison | 1 | SEC filing |
| Jan 3, 2013 | Initial | $31,500 | No comparison | 1 | SEC filing |
| Jan 2, 2013 | Initial | $76,360 | No comparison | 1 | SEC filing |
| Sep 27, 2012 | Amendment | $1,000,000 | $0vs Sep 12, 2012 | 1 | SEC filing |
| Sep 19, 2012 | Amendment | $1,000,000 | $0vs Sep 12, 2012 | 1 | SEC filing |
| Sep 12, 2012 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Apr 13, 2011 | Amendment | $3,356,000 | $1,006,000vs Jan 18, 2011 | 8 | SEC filing |
| Feb 22, 2011 | Amendment | $3,016,000 | $666,000vs Jan 18, 2011 | 6 | SEC filing |
| Jan 18, 2011 | Initial | $2,350,000 | No comparison | 3 | SEC filing |
| Jul 22, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $150K (estimated)
- Form D file number
- 021-228414
The maximum amount that will be paid as finder's fees is $150,000.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Lakers Holdings Ltd | None |
Source: Form D, filed Nov 14, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Berelowitz | Director |
| Joshua Hexter | Executive |
| Harold Jacob | Director |
| Miriam Kidron | Director, Executive |
| Nadav Kidron | Director, Executive |
| Gerald M Ostrov | Director |
| Leonard Sank | Director |
| Yifat Hen Zommer | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
Hi Tech Park 2/4 Givat Ram
Jerusalem, L3, 91390
Jerusalem, L3, 91390